Skip to content

Effectiveness of pay-it-forward incentives in promoting human papilloma virus (HPV) self-sampling testing among female sex worker in China: a cluster randomized trial

Effectiveness of pay-it-forward incentives in promoting human papilloma virus (HPV) self-sampling testing among female sex worker in China: a cluster randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092718
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-28
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human papilloma virus

Interventions

Pay-it-forward arm:Pay-it-forward incentives
Standard-of-care arm:Pay for their tests out-of-pocket

Sponsors

Dematology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Assigned female at birth; 2.Aged 18 years or above; 3.Have engaged in commercial sex within the last 6 months; 4.Have not received or have not completed the full course of HPV vaccination; 5.Have not screened for HPV or cervical cancer in the past 12 months; 6.Have not screened for HPV or cervical cancer in the past 12 months;

Exclusion criteria

Exclusion criteria: 1.Assigned male at birth; 2.Under the age of 18 years; 3.Have not engaged in commercial sex within the last 6 months; 4.Have completed the full course of HPV vaccination; 5.Unwilling to participate in this study or to sign the informed consent form; 6.Have ever participated in the HPV pay-it-forward program;

Design outcomes

Primary

MeasureTime frame
HPV testing rate;

Secondary

MeasureTime frame
Amount of donated by participants in the pay-it-forward arm;Proportion of participants donated for others for HBV/HCV testing in the pay-it-forward arm;

Countries

China

Contacts

Public ContactTang Weiming

Dematology Hospital of Southern Medical University

weiming_tang@med.unc.edu+86 20 8725 5824

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026